Literature DB >> 22226173

A mouse model of CMV transmission following kidney transplantation.

Z Li1, X Wang, S Yan, Z Zhang, C Jie, N Sustento-Reodica, M Hummel, M Abecassis.   

Abstract

Reactivation of latent CMV in transplant recipients remains a significant infectious complication of transplantation. Investigation of the cellular and molecular mechanisms by which reactivation occurs has been hampered by the lack of appropriate animal models. Here, we show that transplantation of kidneys latently infected with murine cytomegalovirus (MCMV) into NOD.Cg-Prkdc(scid) IL2rg(tm1Wjl) /Szj mice results in reactivation of latent virus in the kidney, resulting in a disseminated primary infection of the recipient. This model will be useful in elucidating mechanisms of MCMV reactivation, including the roles of injury and of spontaneous reactivation, and in testing new therapies for treatment and prevention of CMV reactivation and disease. © Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226173     DOI: 10.1111/j.1600-6143.2011.03892.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Authors:  Zheng Zhang; Longhui Qiu; Shixian Yan; Jiao-Jing Wang; Paul M Thomas; Manoj Kandpal; Lihui Zhao; Andre Iovane; Xue-Feng Liu; Edward B Thorp; Qing Chen; Mary Hummel; Yashpal S Kanwar; Michael M Abecassis
Journal:  Am J Transplant       Date:  2019-05-14       Impact factor: 8.086

2.  Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.

Authors:  Xue-Feng Liu; Chunfa Jie; Zheng Zhang; Shixian Yan; Jiao-Jing Wang; Xueqiong Wang; Sunil Kurian; Daniel R Salomon; Michael Abecassis; Mary Hummel
Journal:  J Gen Virol       Date:  2016-01-20       Impact factor: 3.891

Review 3.  New Insights Into the Molecular Mechanisms and Immune Control of Cytomegalovirus Reactivation.

Authors:  Taylor A Heald-Sargent; Eleonora Forte; Xuefeng Liu; Edward B Thorp; Michael M Abecassis; Zheng Jenny Zhang; Mary A Hummel
Journal:  Transplantation       Date:  2020-05       Impact factor: 5.385

4.  Tissue-specific control of latent CMV reactivation by regulatory T cells.

Authors:  Maha Almanan; Jana Raynor; Allyson Sholl; Mei Wang; Claire Chougnet; Rhonda D Cardin; David A Hildeman
Journal:  PLoS Pathog       Date:  2017-08-10       Impact factor: 6.823

5.  MCMV Dissemination from Latently-Infected Allografts Following Transplantation into Pre-Tolerized Recipients.

Authors:  Sahil Shah; Matthew DeBerge; Andre Iovane; Shixian Yan; Longhui Qiu; Jiao-Jing Wang; Yashpal S Kanwar; Mary Hummel; Zheng J Zhang; Michael M Abecassis; Xunrong Luo; Edward B Thorp
Journal:  Pathogens       Date:  2020-07-26

Review 6.  Epigenetic control of cytomegalovirus latency and reactivation.

Authors:  Xue-feng Liu; Xueqiong Wang; Shixian Yan; Zheng Zhang; Michael Abecassis; Mary Hummel
Journal:  Viruses       Date:  2013-05-23       Impact factor: 5.048

Review 7.  Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response.

Authors:  Eleonora Forte; Zheng Zhang; Edward B Thorp; Mary Hummel
Journal:  Front Cell Infect Microbiol       Date:  2020-03-31       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.